Efficacy by baseline disease characteristics of subcutaneous guselkumab induction therapy in patients with moderately to severely active Crohn's disease: Results at Week 12 from the phase 3 GRAVITI study

被引：0

作者：

D'Haens, G. ^{[1
]}

Hisamatsu, T. ^{[2
]}

Steinwurz, F. ^{[3
]}

Hart, A. ^{[4
]}

Liu, W. ^{[5
]}

Olurinde, M. ^{[6
]}

Ngqawa, P. ^{[6
]}

Yang, Z. ^{[6
]}

Merrall, E. ^{[7
]}

Terry, N. A. ^{[6
]}

Sands, B. E. ^{[8
]}

Panaccione, R. ^{[9
]}

机构：

[1] Amsterdam Univ Med Ctr, Gastroenterol, Amsterdam, Netherlands

[2] Kyorin Univ, Gastroenterol, Tokyo, Japan

[3] Hosp Israelita Albert Einstein, Gastroenterol, Sao Paulo, Brazil

[4] London North West Univ Healthcare NHS Trust, Gastroenterol, London, England

[5] Nanjing Med Univ, Affiliated Hosp 3, Peoples Hosp Changzhou 2, Gastroenterol, Changzhou, Peoples R China

[6] Janssen Res & Dev LLC, Immunol, Spring House, PA USA

[7] Janssen Vaccines & Prevent BV, Immunol, Leiden, Netherlands

[8] Icahn Sch Med Mt Sinai, Gastroenterol, New York, NY USA

[9] Univ Calgary, Gastroenterol, Calgary, AB, Canada

来源：

JOURNAL OF CROHNS & COLITIS | 2025年 / 19卷

关键词：

D O I：

10.1093/ecco-jcc/jjae190.1017

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

P0843

引用

页码：I1608 / I1609

页数：2

共 50 条

[21] EFFICACY AND SAFETY OF GUSELKUMAB MAINTENANCE THERAPY IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN'S DISEASE: WEEK 48 ANALYSES FROM THE PHASE 2 GALAXI 1 STUDY [J].

Panaccione, Remo ;

Rubin, David T. ;

Sands, Bruce E. ;

Reinisch, Walter ;

D'Haens, Geert ;

Panes, Julian ;

Gonzalez, Susana ;

Weisel, Kathleen ;

Sahoo, Aparna ;

Frustaci, Mary Ellen S. ;

Yang, Zijiang ;

Sandborn, William J. ;

Afzali, Anita ;

Hisamatsu, Tadakazu ;

Danese, Silvio ;

Andrews, Jane M. ;

Feagan, Brian G. .

GASTROENTEROLOGY, 2022, 162 (07) :S216-S217

[22] Efficacy of Guselkumab in Moderately to Severely Active Crohn's Disease According to Induction Clinical Response Status: Week 48 Results from the GALAXI 2 & 3 Phase 3 Trials [J].

Afzali, Anita ;

Panes, Julian ;

Sands, Bruce E. ;

Rubin, David T. ;

Panaccione, Remo ;

Terry, Natalie A. ;

Salese, Leonardo ;

Van Rampelbergh, Rian ;

Yang, Zijiang ;

Frustaci, Mary Ellen ;

Tarabar, Dino ;

Chen, Minhu ;

Mihaly, Emese ;

Wolf, Douglas ;

D'Haens, Geert R. .

AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S) :S1024-S1025

[23] THE EFFICACY AND SAFETY OF GUSELKUMAB INDUCTION THERAPY IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: PHASE 213 QUASAR STUDY RESULTS THROUGH WEEK 12 [J].

Allegretti, Jessica R. ;

Rubin, David T. ;

Bressler, Brian ;

Huang, Kuan-Hsiang G. ;

Shipitofsky, Nicole ;

Germinaro, Matthew ;

Zhang, Hongyan ;

Johanns, Jewel ;

Feagan, Brian ;

Sandborn, William J. ;

Sands, Bruce E. ;

Hisamatsu, Tadakazu ;

Lichi, Gary R. ;

Lichtenstein, Gary R. ;

Panes, Julian ;

Dignass, Axel .

GASTROENTEROLOGY, 2022, 162 (07) :S963-S964

[24] The Efficacy of Induction Treatment With Guselkumab in Patients With Moderately to Severely Active Ulcerative Colitis: Phase 3 QUASAR Induction Study Results at Week 12 by Prior Advanced Therapy History [J].

Bressler, Brian ;

Peyrin-Biroulet, Laurent ;

Allegretti, Jessica R. ;

Huang, Kuan-Hsiang G. ;

Germinaro, Matthew ;

Shipitofsky, Nicole ;

Miao, Ye ;

Zhang, Hongyan ;

Bortlik, Martin ;

Hlavaty, Tibor ;

Fujii, Toshimitsu ;

Feagan, Brian G. ;

Sands, Bruce E. ;

Dignass, Axel .

AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10) :S806-S807

[25] The Efficacy of Induction Treatment With Guselkumab in Patients With Moderately to Severely Active Ulcerative Colitis: Phase 3 QUASAR Induction Study Results at Week 12 by Prior Advanced Therapy History [J].

Bressler, Brian ;

Peyrin-Biroulet, Laurent ;

Allegretti, Jessica R. ;

Huang, Kuan-Hsiang G. ;

Germinaro, Matthew ;

Shipitofsky, Nicole ;

Miao, Ye ;

Zhang, Hongyan ;

Bortlik, Martin ;

Hlavaty, Tibor ;

Fujii, Toshimitsu ;

Feagan, Brian G. ;

Sands, Bruce E. ;

Dignass, Axel .

AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10S) :S806-S807

[26] Clinical efficacy and safety of guselkumab maintenance therapy in patients with moderately to severely active Crohn's Disease: Week 48 analyses from the phase 2 GALAXI 1 study [J].

Danese, S. ;

Panaccione, R. ;

Rubin, D. T. ;

Sands, B. E. ;

Reinisch, W. ;

D'Haens, G. ;

Panes, J. ;

Gonzalez, S. ;

Weisel, K. ;

Sahoo, A. ;

Frustaci, M. E. ;

Yang, Z. ;

Sandborn, W. J. ;

Afzali, A. ;

Hisamatsu, T. ;

Andrews, J. M. ;

Feagan, B. .

JOURNAL OF CROHNS & COLITIS, 2022, 16 :I026-I027

[27] Clinical Efficacy and Safety of Guselkumab Maintenance Therapy in Patients with Moderately to Severely Active Crohn's Disease: Week 48 Analyses from the Phase 2 GALAXI 1 Study [J].

Danese, Silvio ;

Panaccione, Remo ;

Rubin, David T. ;

Sands, Bruce E. ;

Reinisch, Walter ;

D'Haens, Geert ;

Panes, Julian ;

Gonzalez, Susana ;

Weisel, Kathleen ;

Sahoo, Aparna ;

Frustaci, Mary Ellen ;

Yang, Zijiang ;

Sandborn, William J. ;

Afzali, Anita ;

Hisamatsu, Tadakazu ;

Andrews, Jane M. ;

Feagan, Brian G. .

ARTHRITIS & RHEUMATOLOGY, 2022, 74 :3656-3660

[28] THE EFFICACY AND SAFETY OF GUSELKUMAB INDUCTION THERAPY IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: RESULTS FROM THE PHASE 3 QUASAR INDUCTION STUDY [J].

Allegretti, Jessica R. ;

Peyrin-Biroulet, Laurent ;

Feagan, Brian G. ;

Bressler, Brian ;

Lichtenstein, Gary R. ;

Huang, Kuan-Hsiang G. ;

Germinaro, Matthew ;

Shipitofsky, Nicole ;

Jiang, Lingjing ;

Zhang, Hongyan ;

Hisamatsu, Tadakazu ;

Panes, Julian ;

Dignass, Axel ;

Sands, Bruce E. ;

Rubin, David T. .

GASTROENTEROLOGY, 2023, 164 (06) :S1572-S1572

[29] Efficacy of Mirikizumab by Baseline Disease Location in Moderately to Severely Active Crohn's Disease: Results of the Phase 3 VIVID-1 Study [J].

Barnes, Edward ;

Bossuyt, Peter ;

Ferrante, Marc ;

Siegmund, Britta ;

Durand, Frederick ;

Fisher, Deborah A. ;

Morris, Nathan ;

Yu, Guanglei ;

Bragg, Sonja M. ;

Charabaty, Aline .

AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S) :S739-S739

[30] Efficacy of Induction upadacitinib Therapy in Chinese Patients with Moderately to Severely Active Crohn's Disease [J].

Chen, M. ;

Gao, X. ;

Cao, Q. ;

Zhang, X. ;

Chen, Y. ;

Hou, X. ;

Zhong, J. ;

Sun, Y. ;

Phaleng, X. .

JOURNAL OF CROHNS & COLITIS, 2024, 18 :I1213-I1213

← 1 2 3 4 5 →